Effect of phenothiazines on protein kinase C- and calcium-dependent activation of peritoneal macrophages

Cell Biology and Toxicology

Volumn 19, Issue 1, 2003, Pages 3-12

  Hadjimitova, V ^a   Bakalova, Rumiana ^b,c   Traykov, T ^a   Ohba, H ^b   Ribarov, St ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Ca2+ calmodulin; Chemiluminescence; Cytotoxicity; Macrophages; Protein kinase C

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIMYCIN; CALCIUM ION; CHLORPROMAZINE; LEVOMEPROMAZINE; LUMINOL; PHENOTHIAZINE DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; PROMETHAZINE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; SUPEROXIDE; THIORIDAZINE; TRIFLUOPERAZINE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; IMMUNOMODULATION; MACROPHAGE ACTIVATION; MALE; MOLECULAR MECHANICS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; RESPIRATORY BURST; STRUCTURE ACTIVITY RELATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CALCIMYCIN; CALCIUM; CELL SURVIVAL; ENZYME ACTIVATORS; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MOLECULAR STRUCTURE; PHENOTHIAZINES; PROTEIN KINASE C; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0037293935     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022061513581     Document Type: Article

References (24)

1. Aftab DT, Ballas LM, Loomis CR, Hait WN. Structure activity relationships of phenothiazines and related drugs for inhibition of protein-kinase C. Mol Pharmacol. 1991;40:798-805.
2. Celada A, Schreiber RD. Role of protein kinase C and intracellular calcium mobilization in the induction of macrophage tumorocidal activity by interferon-gamma. J Immunol. 1986;137:2373-9.
3. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12(4):274-77.
4. Crouch SP. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods. 1993;160(1):81-7.
5. Dalla Libera A, Scutari G, Boscolo R, Rigobello MP, Bindoli A. Antioxidant properties of clorazine and related neuroleptics. Free Radic Res. 1998;29:151-7.
6. Ford JM, Prozialeck WC, Hait WN. Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol Pharmacol. 1989;35:105-15.
7. Forman HJ, Torres M. Redox signaling in macrophages. Mol Aspects Med. 2001a;22(4-5):189-216.
8. Forman HJ, Torres M. Signaling by the respiratory burst in macrophages. IUBMN Life. 2001b;51(6):365-71.
9. Hadjimitova V, Traykov T, Goliysky P, Ribarov S. Effect of some psychotropic drugs on the activated macrophage-induced luminol-dependent chemiluminescence. Pharmacol Toxicol. 1999;84(4):170-3.
10. Hait WN, Lazo JS. Calmodulin: a potential target for cancer chemotherapeutic agents. J Clin Oncol. 1994;4:994-1012.
11. Hait WN, Lee GL. Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists. Biochem Pharmacol. 1985;34:3973-8.
12. Hait WN, Gestmonde JF, Lazo JS. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomicin. Anticancer Res. 1994;14:1711-21.
13. Lummis SC, Baker J. Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT3 receptors. Neuropharmacology. 1997;36:665-70.
14. Molnar J, Mandi Y, Petri I et al. Immunomodulation activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines. Anticancer Res. 1993;13:439-42.
15. Morgan RJ Jr, Synold T, Carr BI et al. Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy. Cancer Chemother Pharmacol. 2001;47(4):327-32.
16. Motodashi N. Phenothiazines and calmodulin. Anticancer Res. 1991;11:1125-64.
17. Motodashi N, Sakagami H, Kamata K, Yamamoto Y. Cytotoxicity and differentiation-inducing activity of phenothiazine and benzo[a]phenothiazine derivatives. Anticancer Res. 1991;11:1933-7.
18. Motodashi N, Kawase M, Saito S, Sakagami H. Antitumor potential and possible targets of phenothiazine-related compounds. Curr Drug Targets 2000;1:237-45.
19. Nahata MC, Ford C, Ruymann FB. Pharmacokinetics and safety of prochlorperazine in paediatric patients receiving cancer chemotherapy. J Clin Ther. 1992;17(2):121-3.
20. Nordenberg J, Fenig E, Landau M, Weizman R, Weizman A. Effects of psychotropic drugs on cell proliferation and differentiation. Biochem Pharmacol. 1999;58:1229-36.
21. Satoh K, Sakagami H, Motohashi N. Radical modulation activity of benzo[a]phenothiazine. Anticancer Res. 1997;17 (4A):2539-43.
22. Schwamberger G, Flesch I, Ferber E. Tumorocidal effector molecules of murine macrophages. Pathobiology. 1991;59(4):248-53.
23. Sies H, de Groot H. Role of reactive oxygen species in cell toxicity. Toxicol Lett. 1992;64-65:574-51.
24. Traykov T, Hadjimitova V, Goliysky P, Ribarov S. Effect of phenothiazines on activated macrophage-induced luminol-dependent chemiluminescence. Gen Physiol Biophys. 1997;16:3-14.